• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

FDA clears Endosonics' Oracle-Micro catheter

Article

Intraluminal ultrasounddeveloper Endosonics announced this month that the Food and DrugAdministration has cleared its Oracle-Micro catheter, which combinescoronary balloon angioplasty with ultrasound imaging. Endosonicsclaims that the product is the only

Intraluminal ultrasounddeveloper Endosonics announced this month that the Food and DrugAdministration has cleared its Oracle-Micro catheter, which combinescoronary balloon angioplasty with ultrasound imaging. Endosonicsclaims that the product is the only device that can perform bothpercutaneous transluminal coronary angioplasty (PTCA) and intravascularultrasound on the same catheter.

In clinical studies the company submitted to the FDA, cardiologistsusing Oracle-Micro had different impressions of treatment successand in some cases changed therapy decisions compared to cardiologistswho used conventional angiographic imaging.

Gaining FDA approval for Oracle-Micro was not a cake walk,however. The agency earlier this year asked Endosonics to revisethe data in the application (SCAN 8/31/94). Endosonics won theagency's go-ahead within weeks of resubmitting the application,the company reported.

Endosonics plans limited shipments of the current version ofOracle-Micro to U.S. customers while it submits a series of PMAsupplements for the latest version of the product.

Related Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.